Page last updated: 2024-08-21

arsenic trioxide and ceritinib

arsenic trioxide has been researched along with ceritinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alt, F; Backes, N; Bender, H; Brockmann, MA; Burhenne, J; Faber, J; Filipski, K; Fresnais, M; Glaser, M; Harter, PN; Huprich, S; Lehmann, N; Neu, MA; Paret, C; Pietsch, T; Roth, L; Russo, A; Seidmann, L; Sommer, C; Wagner, W; Wingerter, A	1

Other Studies

1 other study(ies) available for arsenic trioxide and ceritinib

Article	Year
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor. International journal of molecular sciences, 2019, Aug-30, Volume: 20, Issue:17 Topics: Adult; Arsenic Trioxide; Base Sequence; Brain; Brain Neoplasms; Cell Line, Tumor; Child, Preschool; Chromosome Aberrations; DNA Methylation; Female; Germ-Line Mutation; Humans; Insulin-Like Growth Factor I; Molecular Targeted Therapy; Neoplasms, Neuroepithelial; Principal Component Analysis; Pyrimidines; Receptor, Notch1; Sulfones; Transcriptome; Tumor Suppressor Protein p53	2019

Article

Year

Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor.

International journal of molecular sciences, 2019, Aug-30, Volume: 20, Issue:17

Topics: Adult; Arsenic Trioxide; Base Sequence; Brain; Brain Neoplasms; Cell Line, Tumor; Child, Preschool; Chromosome Aberrations; DNA Methylation; Female; Germ-Line Mutation; Humans; Insulin-Like Growth Factor I; Molecular Targeted Therapy; Neoplasms, Neuroepithelial; Principal Component Analysis; Pyrimidines; Receptor, Notch1; Sulfones; Transcriptome; Tumor Suppressor Protein p53

2019